AI-driven drug discovery firms rallied on Friday after the U.S. Food and Drug Administration (FDA) announced an initiative to ...

This partnership will provide Oncolytics with a flexible source of funding, enabling the Company to progress pelareorep toward key clinical milestones and minimize dilution to create and sustain ...

Oncolytics Biotech (TSX:ONC), a clinical-stage cancer therapy company, announced a US$20 million share purchase agreement ...